89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 35 filers reported holding 89BIO INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,481,000 | -9.2% | 225,499 | +11.5% | 0.00% | 0.0% |
Q2 2023 | $3,832,000 | +25.9% | 202,158 | +1.2% | 0.00% | 0.0% |
Q1 2023 | $3,043,000 | +24.8% | 199,836 | +4.3% | 0.00% | 0.0% |
Q4 2022 | $2,438,000 | +220.8% | 191,544 | +46.0% | 0.00% | – |
Q3 2022 | $760,000 | +4966.7% | 131,186 | +2808.8% | 0.00% | – |
Q2 2022 | $15,000 | -88.6% | 4,510 | -87.2% | 0.00% | – |
Q1 2022 | $132,000 | -71.3% | 35,116 | -0.3% | 0.00% | – |
Q4 2021 | $460,000 | -76.1% | 35,225 | -64.1% | 0.00% | -100.0% |
Q3 2021 | $1,922,000 | +72.4% | 98,107 | +64.4% | 0.00% | – |
Q2 2021 | $1,115,000 | -20.3% | 59,666 | +1.0% | 0.00% | – |
Q1 2021 | $1,399,000 | -2.7% | 59,100 | +0.2% | 0.00% | – |
Q4 2020 | $1,438,000 | -3.9% | 59,000 | +1.2% | 0.00% | -100.0% |
Q3 2020 | $1,496,000 | +295.8% | 58,300 | +207.7% | 0.00% | – |
Q2 2020 | $378,000 | -24.9% | 18,946 | -5.0% | 0.00% | – |
Q1 2020 | $503,000 | 0.0% | 19,941 | +4.3% | 0.00% | – |
Q4 2019 | $503,000 | – | 19,127 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 11,416,948 | $173,880,118 | 3.94% |
Orchard Capital Management, LLC | 551,879 | $8,405,117 | 2.81% |
Cormorant Asset Management, LP | 2,800,000 | $42,644 | 2.81% |
SILVERARC CAPITAL MANAGEMENT, LLC | 438,215 | $6,674,014 | 2.76% |
Boxer Capital, LLC | 2,100,000 | $31,983 | 1.57% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,210,536 | $33,666,463 | 1.42% |
Resolute Capital Asset Partners LLC | 125,000 | $1,904 | 1.39% |
Velan Capital Investment Management LP | 98,500 | $1,500,155 | 1.28% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $3,046,000 | 1.26% |
Deep Track Capital, LP | 1,800,000 | $27,414,000 | 1.13% |